Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement
Autor: | Mg Marrosu, G. Illomei, Gabriella Spinicci, E. Locci |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male medicine.medical_specialty Multiple Sclerosis Neurology Dermatology 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine medicine Humans Spasticity Neuroradiology medicine.diagnostic_test business.industry Multiple sclerosis General Medicine Gold standard (test) Middle Aged medicine.disease Psychiatry and Mental health Cross-Sectional Studies Muscle Spasticity Anesthesia Physical therapy Elasticity Imaging Techniques Female Neurology (clinical) Neurosurgery Elastography Imaging technique medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Neurological Sciences. 38:433-439 |
ISSN: | 1590-3478 1590-1874 |
DOI: | 10.1007/s10072-016-2780-x |
Popis: | Multiple sclerosis (MS) spasticity is currently evaluated on the basis of neurological examinations such as Ashworth Scale (AS) and 0–10 NRS. Severity of spasticity is difficult to quantify. We investigated the use of real time elastography (RTHE) ultrasounds for evaluating objectively the muscle fibers status in MS spasticity patients and their changes after a new antispasticity treatment. Two studies were performed. In study A, 110 MS patients underwent a neurological evaluation based on the AS and RTHE. The RTHE images were scored with the new 1-5 muscle fibers rigidity imaging scale, here called MEMSs (Muscle Elastography Multiple Sclerosis Score). The correlation between AS and MEMSs was found to be statistically significant. In study B, 55 MS patients treated with THC:CBD oromucosal spray for their resistant spasticity were followed prospectively. MS spasticity was evaluated by the 0–10 NRS scale at baseline and after 4 weeks of treatment. MEMSs’ figures were obtained at both timepoints. Responders to THC:CBD oromucosal spray (pre-defined as an improvement ≥20% in their 0–10 NRS spasticity score vs. baseline) were 65% of sample. These patients had a mean 0-10 NRS reduction of 1.87 and a MEMSs reduction of 1.97 (P values |
Databáze: | OpenAIRE |
Externí odkaz: |